ReferIndia News Aurobindo Pharma Arm CuraTeQ Gets Health Canada Nod For Biosimilar

ReferIndia News

Want to grow your business digitally?

Let us help you get there—fast, smart, and effective.

Contact Now
News Image

Aurobindo Pharma Arm CuraTeQ Gets Health Canada Nod For Biosimilar

Published on: May 1, 2026, 3:16 p.m. | Source: NDTV Profit

Available in 100 mg and 400 mg formulations, the originator product Avastin is marketed by Roche/Genentech, filing added.

Checkout more news
Ad Banner

Looking for free cloud deployment?

Sign up & get $200 free credit for 60 days to launch your first Droplet or GPU server on DigitalOcean 🚀

Signup Now
ReferIndia News contact